{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":478,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":478,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"0cbf4ae88630","filters":{"venue":"Arthritis & Rheumatism"}},"results":[{"id":"W2128952811","doi":"10.1002/art.27584","title":"2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative","year":2010,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9560,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Women's College Hospital; University of Toronto; Mount Sinai Hospital","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Rheumatism; Medicine; Rheumatology; Rheumatoid arthritis; Synovitis; Internal medicine; Disease; Physical therapy; League; Arthritis","retraction":null,"screen_n_in":null,"score":{"opus":0.0186868547307505,"gpt":0.2832290376047507,"spread":0.2645421828740002,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001841891,0.0009481066,0.002325005,0.000918841,0.0007965549,0.0001887137,0.0007589551,0.0003714737,0.001544391],"category_scores_gemma":[0.001542314,0.0009974578,0.0003683626,0.001458475,0.003333713,0.001614706,0.0002518896,0.001642433,0.0004864615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001002299,"about_ca_system_score_gemma":0.0008392737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008525414,"about_ca_topic_score_gemma":0.004764906,"domain_scores_codex":[0.9920525,0.001374052,0.002497718,0.001364105,0.001302958,0.001408661],"domain_scores_gemma":[0.9935901,0.0006799821,0.001345653,0.001774761,0.001493345,0.001116213],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0008243772,0.002045087,0.03710979,0.0001941339,0.0007831916,0.0005096963,0.01011554,0.000004416514,0.09477734,0.04137493,0.02126138,0.7910001],"study_design_scores_gemma":[0.05540175,0.01257647,0.7309747,0.03044066,0.00005809025,0.01323457,0.04574796,0.005597444,0.02729446,0.01455921,0.05746939,0.006645331],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9736392,0.01017184,0.000534802,0.002196978,0.001298852,0.00190284,0.001787556,0.000526462,0.007941394],"genre_scores_gemma":[0.7725331,0.2178236,0.008174172,0.0002626191,0.00004830824,0.0002436014,0.0006313584,0.0002004076,0.00008284542],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7843548,"threshold_uncertainty_score":0.9993786,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159860161","doi":"10.1002/art.34473","title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","year":2012,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":5295,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Dalhousie University; University Health Network; Capital District Health Authority; Université Laval; Toronto Western Hospital; Centre hospitalier universitaire de Québec","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Systemic lupus; Medicine; Systemic disease; Systemic lupus erythematosus; Immunology; Dermatology; Immunopathology; Internal medicine; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.03945545159991799,"gpt":0.3298321007901709,"spread":0.290376649190253,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001690464,0.0002172116,0.000522839,0.0001828822,0.0002107091,0.00008581547,0.0002115603,0.0001993216,0.0000381633],"category_scores_gemma":[0.00128321,0.0001782491,0.000115295,0.0003358835,0.0001334021,0.0004672506,0.00008989518,0.0001587759,0.0000160001],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002418918,"about_ca_system_score_gemma":0.0001674382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000204416,"about_ca_topic_score_gemma":0.000007718358,"domain_scores_codex":[0.9971806,0.0002632299,0.001198971,0.0003185325,0.0006650576,0.0003736496],"domain_scores_gemma":[0.9972412,0.000541531,0.0007437348,0.0005322178,0.0008032337,0.0001380548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.000162679,0.000147587,0.9037479,0.003004212,0.0001812501,0.000001948539,0.01006337,0.000007526515,0.05852843,0.008213149,0.003073544,0.01286839],"study_design_scores_gemma":[0.04641253,0.001155642,0.06548335,0.1137432,0.0006794347,0.6072099,0.07564173,0.04409903,0.03519767,0.003435581,0.004749507,0.002192373],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839512,0.006105714,0.003586796,0.0007074274,0.003012707,0.002261512,0.00005514877,0.00007235686,0.0002472129],"genre_scores_gemma":[0.9947581,0.001967342,0.002063181,0.0000471559,0.0002402949,0.0004144228,0.0001103625,0.00005362063,0.0003454761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8382646,"threshold_uncertainty_score":0.7268787,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2083180635","doi":"10.1002/art.21972","title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","year":2006,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":3721,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Psoriatic arthritis; Medicine; Logistic regression; Psoriasis; Internal medicine; Rheumatoid arthritis; Gold standard (test); Receiver operating characteristic; Enthesitis; Arthritis; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.03056501278391496,"gpt":0.316435695787343,"spread":0.2858706830034281,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002428352,0.0002949567,0.000673459,0.0001589786,0.0002341496,0.00007003285,0.0001442845,0.00009711736,0.001096637],"category_scores_gemma":[0.0001112222,0.0003083466,0.0001436788,0.0001452609,0.00004734329,0.0002172317,0.00008309261,0.00009045392,0.00006533432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001129375,"about_ca_system_score_gemma":0.0001619878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008140232,"about_ca_topic_score_gemma":0.004611256,"domain_scores_codex":[0.9975052,0.00004714078,0.001083696,0.0005119784,0.0004601092,0.0003918312],"domain_scores_gemma":[0.9988815,0.00009645872,0.0002930445,0.0003634184,0.0002383944,0.0001271839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001163909,0.005222588,0.06813338,0.00007612366,0.001158953,0.00009946085,0.009702578,6.512327e-7,0.003324122,0.00293532,0.02782789,0.880355],"study_design_scores_gemma":[0.03807202,0.001817472,0.9209689,0.002574691,0.0001371162,0.00005655184,0.003207927,0.0002943689,0.001354154,0.004622139,0.02639204,0.0005025688],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984264,0.00799804,0.002979566,0.000509708,0.00120763,0.001651083,0.0003923014,0.0001056489,0.0008920793],"genre_scores_gemma":[0.9660243,0.001039326,0.03077235,0.00007515027,0.0002931457,0.0004340062,0.0009877596,0.00004819568,0.0003257169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8798525,"threshold_uncertainty_score":0.9999369,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2508060872","doi":"10.1002/art.38098","title":"2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative","year":2013,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":3406,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McGill University; Toronto Western Hospital; Jewish General Hospital; St Joseph's Health Care; University of Toronto; Mount Sinai Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Institutes of Health Research; University of Oxford; Gilead Sciences; Genentech; GlaxoSmithKline; Pfizer","keywords":"Medicine; Rheumatism; Rheumatology; Internal medicine; Scleroderma (fungus); Dermatology; Physical therapy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03500384499969365,"gpt":0.2735314758133565,"spread":0.2385276308136628,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000633578,0.0004774916,0.00139925,0.0003431773,0.0003164296,0.0000767335,0.0002974968,0.000204153,0.0002311046],"category_scores_gemma":[0.0004027804,0.0004401144,0.0002361684,0.0006545614,0.0006590334,0.0007028657,0.00005764659,0.0002259038,0.000261228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001335526,"about_ca_system_score_gemma":0.0002857757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007074525,"about_ca_topic_score_gemma":0.0000863454,"domain_scores_codex":[0.9956633,0.0008170179,0.001761268,0.0007347397,0.0004494454,0.0005741923],"domain_scores_gemma":[0.995832,0.0004348662,0.001258999,0.0007791237,0.001240754,0.000454256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006712518,0.002493437,0.03138224,0.002258392,0.002098088,0.0000510075,0.01972125,0.00005995774,0.2087614,0.01365345,0.2116286,0.507221],"study_design_scores_gemma":[0.02662486,0.005259865,0.6584737,0.1769118,0.0005155706,0.001807229,0.1069714,0.01486469,0.004117295,0.001344143,0.0005908738,0.00251855],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9726202,0.01903554,0.0008295251,0.00141791,0.0004359244,0.003553555,0.0009096557,0.0002493901,0.0009482601],"genre_scores_gemma":[0.9403706,0.05481045,0.002819396,0.0003273679,0.00003723019,0.000994183,0.0004606585,0.0001172874,0.00006288863],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6270915,"threshold_uncertainty_score":0.9998051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979364075","doi":"10.1002/art.10697","title":"Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1763,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Placebo; Methotrexate; Concomitant; Internal medicine; Rheumatology; Gastroenterology; Tumor necrosis factor alpha; Arthritis; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02924629943046196,"gpt":0.3145420472270967,"spread":0.2852957477966347,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009794075,0.0005992798,0.00148058,0.0002759503,0.0008234275,0.0001922965,0.0003832916,0.0001554968,0.0007280937],"category_scores_gemma":[0.0007409427,0.0003953207,0.0006024395,0.0004706405,0.0006581233,0.0003187476,0.00005533108,0.0003685459,0.00002002436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001830161,"about_ca_system_score_gemma":0.0003455443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002054135,"about_ca_topic_score_gemma":0.001427321,"domain_scores_codex":[0.9949974,0.000596982,0.001688043,0.0006680553,0.0009583206,0.001091197],"domain_scores_gemma":[0.9962795,0.001490644,0.0007392862,0.0008856349,0.0003395036,0.0002653855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01502902,0.006651363,0.12007,0.0001542159,0.001878223,0.0001611636,0.01285511,0.00003461176,0.01043457,0.02141406,0.001630152,0.8096875],"study_design_scores_gemma":[0.5418175,0.02361248,0.3335799,0.008042214,0.00005117167,0.0004794113,0.003262398,0.0007086545,0.01990858,0.005521535,0.0611768,0.001839307],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9520019,0.04080944,0.0003153507,0.0005043936,0.0005820077,0.005058402,0.0003114353,0.00007141976,0.0003456021],"genre_scores_gemma":[0.8392227,0.1589052,0.0006672407,0.0001117012,0.0000451154,0.000808701,0.0001016491,0.00008744926,0.00005029458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8078482,"threshold_uncertainty_score":0.9998499,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024644107","doi":"10.1002/art.22025","title":"Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks","year":2006,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1640,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Center for Research Resources","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Internal medicine; Placebo; Rheumatology; Rheumatism; Randomized controlled trial; Clinical endpoint; Population; Surgery; Physical therapy; Lymphoma; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0311017115630682,"gpt":0.3213398643868879,"spread":0.2902381528238197,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004094114,0.0009465146,0.004832618,0.0006974018,0.0008528067,0.0002788342,0.0003689602,0.0003101105,0.0003909909],"category_scores_gemma":[0.002238051,0.0008430435,0.0009601647,0.000397334,0.0007517775,0.0006217849,0.0002636453,0.0005716804,0.00005239849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002378332,"about_ca_system_score_gemma":0.0004549308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001679868,"about_ca_topic_score_gemma":0.0005145792,"domain_scores_codex":[0.9907753,0.0008966574,0.003933785,0.001358056,0.001601642,0.00143452],"domain_scores_gemma":[0.9921774,0.004046859,0.001358186,0.0009865186,0.0007069411,0.0007241422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7680854,0.00254925,0.00004660681,0.0001014563,0.0006567742,0.00004383867,0.001293506,0.000007300019,0.01259233,0.0001918077,0.001761901,0.2126698],"study_design_scores_gemma":[0.9779423,0.006585768,0.0002899074,0.005094925,0.00003756397,0.0002240214,0.000138044,0.0008021513,0.002590108,0.0002149158,0.005320898,0.0007593345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9151705,0.05831928,0.0007122993,0.001026032,0.0006348224,0.02242904,0.00086118,0.0002215018,0.0006253507],"genre_scores_gemma":[0.8272531,0.1655463,0.003178404,0.0002286569,0.0001816469,0.002577547,0.0004760126,0.0001583377,0.000400015],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2119105,"threshold_uncertainty_score":0.999402,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2044410409","doi":"10.1002/1529-0131(200110)44:10<2331::aid-art395>3.0.co;2-i","title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","year":2001,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1202,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal General Hospital; Université de Montréal; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Stroke (engine); Myocardial infarction; Framingham Risk Score; Cardiology; Angina; Framingham Heart Study; Confidence interval; Risk factor; Unstable angina; Heart failure; Logistic regression; Proportional hazards model; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.05136795219941887,"gpt":0.285328204705223,"spread":0.2339602525058041,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009767856,0.0004998506,0.001129413,0.0006487273,0.0002872189,0.0001838506,0.0003654301,0.0003379795,0.0006211483],"category_scores_gemma":[0.000809135,0.0004674782,0.0002752495,0.0009003633,0.0001087249,0.0003781862,0.00008699336,0.000473537,0.0003281255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006416412,"about_ca_system_score_gemma":0.0002659968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009859774,"about_ca_topic_score_gemma":0.0006865034,"domain_scores_codex":[0.9956071,0.000186418,0.001250629,0.0008371445,0.001036062,0.001082674],"domain_scores_gemma":[0.9973224,0.0008139605,0.0002825693,0.0007180725,0.0003560903,0.0005068394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00040084,0.0004594386,0.9564685,0.0006879164,0.000228714,0.0001041312,0.01118416,0.0001264207,0.005573207,0.001038703,0.00879128,0.01493673],"study_design_scores_gemma":[0.0932272,0.006838195,0.5316797,0.1020731,0.0003586798,0.1718824,0.05054909,0.01212416,0.006323699,0.007292069,0.01181752,0.005834194],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894348,0.002674556,0.002265736,0.0004170495,0.0008519774,0.003357057,0.0003095032,0.0002526699,0.0004366491],"genre_scores_gemma":[0.9923474,0.004013236,0.001149313,0.0001314207,0.000143999,0.001198554,0.0001755015,0.0001447665,0.0006958537],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4247888,"threshold_uncertainty_score":0.9997777,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130077869","doi":"10.1002/art.21955","title":"Mortality in systemic lupus erythematosus","year":2006,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1187,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Royal University Hospital; Toronto Western Hospital; University of British Columbia; Dalhousie University; Hôpital Maisonneuve-Rosemont; Université de Montréal; St. Joseph's Hospital; McGill University; University of Calgary; University of Manitoba; Montreal General Hospital","funders":"Medical Research Council; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; University of Toronto; Canadian Arthritis Network; Arthritis Society; Lupus Canada; Lupus Research Alliance; Arthritis Foundation","keywords":"Medicine; Standardized mortality ratio; Cohort; Mortality rate; Population; Confidence interval; Systemic lupus erythematosus; Cohort study; Internal medicine; Epidemiology; Demography; Disease; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.01736161049893811,"gpt":0.2782791699116818,"spread":0.2609175594127437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008906539,0.0003015602,0.0008811852,0.0003723211,0.00009259346,0.00006339506,0.0002053492,0.0002066595,0.0004004974],"category_scores_gemma":[0.0001580363,0.0002874793,0.0001656374,0.0005445101,0.0001538319,0.0002045285,0.00009506387,0.0003586036,0.0006807827],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003158078,"about_ca_system_score_gemma":0.0001866759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003389459,"about_ca_topic_score_gemma":0.002061469,"domain_scores_codex":[0.9965021,0.0001810269,0.001101639,0.00055205,0.0008969433,0.0007662646],"domain_scores_gemma":[0.9984612,0.0001841996,0.0001716154,0.0008546679,0.0001345209,0.0001938074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.00003591712,0.0002150915,0.9785433,0.000809304,0.00004446536,0.0009381953,0.0006046746,0.00001408284,0.001987407,0.005910798,0.005030416,0.005866393],"study_design_scores_gemma":[0.02752529,0.000453257,0.3373919,0.04586158,0.00007174077,0.565841,0.002913365,0.001915226,0.001906315,0.01250197,0.002182736,0.001435669],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9648055,0.01732664,0.0001832535,0.0002277319,0.000577554,0.001144238,0.00001711107,0.0002297805,0.01548821],"genre_scores_gemma":[0.9949118,0.00208881,0.0004247815,0.00005117615,0.0001156002,0.0002245134,0.0000477666,0.00006955243,0.002066036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6411514,"threshold_uncertainty_score":0.9999577,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2046628605","doi":"10.1002/art.20217","title":"Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo‐controlled, 52‐week trial","year":2004,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1171,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; University of Toronto","funders":"","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Concomitant; Internal medicine; Placebo; Rheumatology; Methotrexate; Infliximab; Gastroenterology; Randomized controlled trial; Synovitis; Surgery; Tumor necrosis factor alpha; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02185641912536996,"gpt":0.2936024261355272,"spread":0.2717460070101573,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012606,0.0008577807,0.004664111,0.0007813167,0.0004239179,0.0001679769,0.0001684633,0.0002149624,0.0002952402],"category_scores_gemma":[0.0003816054,0.0005792574,0.0007059658,0.0005074043,0.001823817,0.0006724881,0.00006274847,0.000588417,0.000006757828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001605065,"about_ca_system_score_gemma":0.0006019399,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003099528,"about_ca_topic_score_gemma":0.001616777,"domain_scores_codex":[0.9937507,0.001026907,0.002232142,0.001011678,0.001076231,0.0009023511],"domain_scores_gemma":[0.9958305,0.001729009,0.0009594735,0.0005881255,0.0003927991,0.0005001016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6120961,0.002895044,0.2757248,0.00002624969,0.003422904,0.0001074422,0.001469959,0.00001699036,0.0002117895,0.0007114439,0.00001237148,0.1033049],"study_design_scores_gemma":[0.7153946,0.01220558,0.2678909,0.002837703,0.00002847583,0.00009463634,0.0002567606,0.00002225411,0.0001646037,0.0006003164,0.00003997584,0.0004642835],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784327,0.01330599,0.0002654324,0.0003112894,0.0002001712,0.007025553,0.000217689,0.0001083639,0.0001328061],"genre_scores_gemma":[0.8197465,0.1775726,0.001555739,0.00007220023,0.00002748419,0.0007682955,0.0001384172,0.00009882783,0.00001996071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1642666,"threshold_uncertainty_score":0.9996659,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078769393","doi":"10.1002/art.20256","title":"Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: The arthritis, diet, and activity promotion trial","year":2004,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1077,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Center for Research Resources; National Institute on Aging","keywords":"Medicine; WOMAC; Osteoarthritis; Overweight; Physical therapy; Randomized controlled trial; Weight loss; Body mass index; Knee pain; Obesity; Preferred walking speed; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.006476049144920295,"gpt":0.2148648414667959,"spread":0.2083887923218757,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002680564,0.0005228646,0.0008408302,0.0001847649,0.0003570525,0.0001346396,0.00007211336,0.0002430546,0.00006404358],"category_scores_gemma":[0.00004366009,0.0004011123,0.00007794818,0.000249185,0.0005174817,0.0007882667,0.0001244298,0.0004424318,0.00001144385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006154927,"about_ca_system_score_gemma":0.000100424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004858603,"about_ca_topic_score_gemma":0.005143455,"domain_scores_codex":[0.9974384,0.0001109565,0.0005061079,0.0008420622,0.0004721028,0.0006303147],"domain_scores_gemma":[0.9988727,0.0001007077,0.0001692444,0.000440826,0.00007221573,0.0003443263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01423735,0.000754088,0.003758797,0.0001566743,0.0000434406,0.0008920677,0.003582198,4.626844e-7,0.0002719773,0.000703386,0.000019189,0.9755804],"study_design_scores_gemma":[0.6720099,0.0570094,0.1732118,0.07546876,0.0003023806,0.006604749,0.001599971,0.00004892777,0.004435766,0.007183364,0.0003733713,0.001751693],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9273651,0.06706761,0.00002074461,0.00122425,0.0002366428,0.003688735,0.0000487349,0.0001065159,0.0002417289],"genre_scores_gemma":[0.9209483,0.07737909,0.0006570491,0.00008909998,0.00009614574,0.0006262854,0.00005468912,0.00006473761,0.00008457503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9738287,"threshold_uncertainty_score":0.9998441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009524387","doi":"10.1002/1529-0131(200106)44:6<1237::aid-art214>3.0.co;2-f","title":"Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets","year":2001,"lang":"en","type":"review","venue":"Arthritis & Rheumatism","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1076,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Osteoarthritis; Selection (genetic algorithm); Medicine; Disease; Musculoskeletal disease; Therapeutic approach; Bioinformatics; Intensive care medicine; Internal medicine; Biology; Pathology; Computer science; Alternative medicine; Artificial intelligence","retraction":null,"screen_n_in":null,"score":{"opus":0.02528810055749028,"gpt":0.3038549469827008,"spread":0.2785668464252105,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002856318,0.0006105638,0.001584275,0.0002302315,0.0003222713,0.00007785152,0.0002565739,0.0003730065,0.0004125854],"category_scores_gemma":[0.00005468145,0.0004818729,0.0008261153,0.0003283252,0.0001149694,0.000299466,0.00004734722,0.000318125,0.00005441452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001116459,"about_ca_system_score_gemma":0.0008189637,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004878291,"about_ca_topic_score_gemma":0.0001462462,"domain_scores_codex":[0.9971008,0.0001438765,0.001111095,0.0006518482,0.0004587786,0.0005336322],"domain_scores_gemma":[0.9978052,0.0001374791,0.000668348,0.0007809954,0.0002022456,0.0004056722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008282479,0.000135518,0.00001042348,0.001934723,0.0001936334,0.00002083129,0.00006717949,0.000001042975,0.00006552703,0.001551092,0.0004421268,0.9954951],"study_design_scores_gemma":[0.005858671,0.002648774,0.0001990622,0.03643597,0.002773474,0.001086147,0.00005361345,0.00004500646,0.00007641675,0.001969904,0.9481665,0.0006864066],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001916177,0.99138,0.001891552,0.0001138253,0.0006266639,0.005393869,0.0001870921,0.0001647577,0.0000506519],"genre_scores_gemma":[0.002997969,0.9921387,0.0006822451,0.00004681046,0.0005351366,0.00133605,0.001446862,0.0001663788,0.0006498595],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9948087,"threshold_uncertainty_score":0.9997633,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007511577","doi":"10.1002/1529-0131(200110)45:5<453::aid-art365>3.0.co;2-w","title":"The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties","year":2001,"lang":"en","type":"review","venue":"Arthritis & Rheumatism","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":1021,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"WOMAC; Osteoarthritis; Physical therapy; Medicine; Index (typography); Alternative medicine; Computer science; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04957203863063329,"gpt":0.2703430200773718,"spread":0.2207709814467385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000722027,0.0003797183,0.001637257,0.00009018064,0.0002051313,0.00004583722,0.0001020812,0.0001741099,0.0002030647],"category_scores_gemma":[0.0001176991,0.0002456337,0.0002514822,0.0001630481,0.0004309437,0.0001674278,0.0001237608,0.0003315171,0.000007491788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001465116,"about_ca_system_score_gemma":0.0005182274,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001754257,"about_ca_topic_score_gemma":0.01682109,"domain_scores_codex":[0.9976181,0.000273962,0.0008706598,0.0003954523,0.000572816,0.0002690036],"domain_scores_gemma":[0.9987697,0.00008261661,0.0003568893,0.0003321339,0.0003325875,0.0001261004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001344453,0.00003360604,0.0001673782,0.106125,0.0001091214,0.000005580395,0.0005132434,3.54403e-9,2.316033e-7,0.00003427782,0.000210364,0.8927878],"study_design_scores_gemma":[0.0006874958,0.000297229,0.00219294,0.389274,0.0002316707,0.0001720045,0.0001881514,6.618703e-7,1.291014e-7,0.00001986188,0.6067664,0.0001694844],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001080229,0.994527,0.000005242383,0.0004223595,0.00009867716,0.00233732,0.0000181191,0.00002198819,0.001489083],"genre_scores_gemma":[0.001709107,0.9969471,0.00001883636,0.00009155439,0.00001573671,0.0001207879,0.00001924538,0.000030483,0.001047215],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8926183,"threshold_uncertainty_score":0.9999996,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099334955","doi":"10.1002/art.30129","title":"American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","year":2011,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1019,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; University of Toronto; University of Ottawa","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Versus Arthritis; National Institute for Health and Care Research; Amgen","keywords":"Rheumatism; Medicine; Rheumatology; Rheumatoid arthritis; Clinical trial; Internal medicine; Physical therapy; League; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09739374255231979,"gpt":0.3569379307576577,"spread":0.2595441882053379,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01017414,0.0005892093,0.003780402,0.0008561338,0.0002069316,0.00002321992,0.0004662259,0.0003046138,0.0005370944],"category_scores_gemma":[0.008656734,0.0005643531,0.0009232702,0.0007003268,0.001609512,0.0004545287,0.0001951145,0.0006821065,0.00005983742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007005042,"about_ca_system_score_gemma":0.000584159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008634148,"about_ca_topic_score_gemma":0.0006308833,"domain_scores_codex":[0.988619,0.002622097,0.005920982,0.0009393005,0.0009330083,0.0009655853],"domain_scores_gemma":[0.9926865,0.002944204,0.002255262,0.0009270014,0.0006185391,0.0005684559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002529119,0.001975302,0.09427864,0.0004086404,0.0003984575,0.0001365184,0.002043935,0.000001385676,0.002448649,0.02844027,0.005316044,0.8620231],"study_design_scores_gemma":[0.1304989,0.02006442,0.5627329,0.1585075,0.00006412373,0.004470045,0.009363336,0.001675465,0.01390572,0.08288902,0.01207557,0.003752984],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9594681,0.03009542,0.001419457,0.0004030661,0.0004722768,0.002851634,0.0009638136,0.0001432759,0.004183011],"genre_scores_gemma":[0.6297164,0.3511094,0.01863393,0.00005993168,0.00001429058,0.0001660146,0.0001895284,0.00009107865,0.00001938508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.85827,"threshold_uncertainty_score":0.9996938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2133696182","doi":"10.1002/art.21306","title":"Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial","year":2005,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":905,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Adalimumab; Medicine; Psoriatic arthritis; Placebo; Psoriasis; Internal medicine; Dermatology Life Quality Index; Rheumatology; Psoriasis Area and Severity Index; Quality of life (healthcare); Placebo-controlled study; Surgery; Rheumatoid arthritis; Gastroenterology; Dermatology; Double blind; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01776638192438612,"gpt":0.269517016177703,"spread":0.2517506342533168,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003952192,0.0004958255,0.002611377,0.0001876081,0.0002759708,0.00003340787,0.000127544,0.0001274667,0.0000743823],"category_scores_gemma":[0.000297664,0.0003024903,0.0006069724,0.0002446251,0.0002400509,0.0001814315,0.00003243967,0.00009658478,0.00001644911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001620917,"about_ca_system_score_gemma":0.000179416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007263169,"about_ca_topic_score_gemma":0.002175828,"domain_scores_codex":[0.9965943,0.0001475836,0.001539154,0.0005376495,0.0006610401,0.0005202888],"domain_scores_gemma":[0.9964161,0.001541724,0.0007243038,0.000580936,0.0005451656,0.00019176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7111174,0.002195362,0.00001048948,0.00001807464,0.002176708,0.000006076387,0.003170601,0.0001390549,0.000001023262,0.0002816279,0.0001741404,0.2807094],"study_design_scores_gemma":[0.9818986,0.01282548,0.0009116391,0.001131546,0.0007261835,0.00001385164,0.0003651265,0.0002880323,0.0004269037,0.0001358727,0.001011036,0.000265697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9573707,0.01116329,0.0003596343,0.001212646,0.0003964741,0.02787744,0.000672858,0.00004995971,0.0008970196],"genre_scores_gemma":[0.975207,0.01374601,0.002569629,0.00008227777,0.0001447714,0.007715637,0.0001548373,0.000060604,0.0003192462],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2804437,"threshold_uncertainty_score":0.9999427,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089973119","doi":"10.1002/1529-0131(200108)45:4<384::aid-art352>3.0.co;2-0","title":"Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities","year":2001,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":774,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Ministerul Cercetării, Inovării şi Digitalizării","keywords":"Minimal clinically important difference; WOMAC; Osteoarthritis; Medicine; Sample size determination; Physical therapy; Rehabilitation; Quality of life (healthcare); SF-36; Randomized controlled trial; Surgery; Statistics; Mathematics; Internal medicine; Health related quality of life; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04246458259702043,"gpt":0.2705391183318325,"spread":0.228074535734812,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005482093,0.0001760708,0.0005992418,0.00008890776,0.00008171454,0.00001332013,0.00006100753,0.00007071559,0.00001483246],"category_scores_gemma":[0.0005311331,0.0001224303,0.00008222037,0.0001456012,0.0003352929,0.0001629687,0.00004347529,0.00006161744,2.395578e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003718164,"about_ca_system_score_gemma":0.00009720736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000527446,"about_ca_topic_score_gemma":0.004841201,"domain_scores_codex":[0.9979751,0.0001128197,0.0011763,0.0002741006,0.0002738214,0.0001878779],"domain_scores_gemma":[0.9982233,0.0003347774,0.0007447547,0.0002667471,0.00035722,0.0000732003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001717193,0.0004689488,0.8422258,0.000149745,0.00004726778,1.406883e-7,0.000638324,4.60438e-7,0.002073856,0.0001676514,5.568648e-7,0.15251],"study_design_scores_gemma":[0.01431254,0.01064641,0.9670095,0.004865143,0.00004826982,0.000006474234,0.00106313,0.00001589481,0.0006889116,0.001220425,0.000002208975,0.0001211183],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996406,0.001541562,0.0002266316,0.0000933313,0.00004282541,0.001445807,0.000218796,0.000009040918,0.00001600476],"genre_scores_gemma":[0.9926763,0.0004686854,0.006679532,0.000009671661,0.00000517201,0.0001156363,0.00002584042,0.00001667928,0.000002540457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1523889,"threshold_uncertainty_score":0.4992564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975137544","doi":"10.1002/art.11325","title":"Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":763,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Etanercept; Medicine; Ankylosing spondylitis; Placebo; Rheumatoid arthritis; Psoriatic arthritis; Internal medicine; Spondylitis; Adverse effect; Randomized controlled trial; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01675736581753739,"gpt":0.2768359903796511,"spread":0.2600786245621137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001124516,0.0006721263,0.003958635,0.0002451545,0.0009887433,0.0001741893,0.0001160784,0.0001818026,0.003273305],"category_scores_gemma":[0.002483913,0.0005509318,0.001441972,0.000241715,0.0002917937,0.0002548966,0.00003933378,0.0002534668,0.00008127173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002234384,"about_ca_system_score_gemma":0.0001468405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004658667,"about_ca_topic_score_gemma":0.0002049952,"domain_scores_codex":[0.9953192,0.000534186,0.001841901,0.0008164503,0.000509749,0.0009784722],"domain_scores_gemma":[0.9968951,0.001336851,0.0006425666,0.0005206988,0.0002636093,0.000341174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9228858,0.001671545,0.0008122976,0.0001556627,0.002127636,0.0001973658,0.002813139,8.914396e-7,0.001628167,0.01639925,0.001640158,0.04966811],"study_design_scores_gemma":[0.9868289,0.002526313,0.0001783799,0.002431332,0.0004202547,0.0002932277,0.0004343303,0.0000372215,0.0005029537,0.001830301,0.003986387,0.0005303996],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9652212,0.01138716,0.0002382543,0.0002713002,0.001884381,0.01415673,0.00031749,0.0002454934,0.006278025],"genre_scores_gemma":[0.9803337,0.003851407,0.005903095,0.0001878813,0.0001725335,0.006209422,0.0003156591,0.0001362686,0.002889997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06394312,"threshold_uncertainty_score":0.9996942,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091732273","doi":"10.1002/art.10308","title":"Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two‐year radiographic and clinical outcomes","year":2002,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":733,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Etanercept; Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Rheumatology; Randomized controlled trial; Gastroenterology; Arthritis; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01969233436589057,"gpt":0.2814224959992386,"spread":0.2617301616333481,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007813236,0.0005346881,0.001377847,0.0006183481,0.0002555563,0.0001948406,0.0002247052,0.0002188677,0.001386567],"category_scores_gemma":[0.0004435752,0.000467286,0.0002789158,0.0006535229,0.0008320971,0.0006792881,0.0001167059,0.00086354,0.0002778186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000500586,"about_ca_system_score_gemma":0.00004950192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007090461,"about_ca_topic_score_gemma":0.001771523,"domain_scores_codex":[0.9954172,0.0004582852,0.001220941,0.0008723775,0.0009947524,0.001036401],"domain_scores_gemma":[0.9975206,0.0006328461,0.0002316176,0.0007348863,0.0001953649,0.0006846962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005522623,0.0004619699,0.7036892,0.00001256418,0.0002938538,0.0001213787,0.0005491111,6.234884e-7,0.000002554538,0.0008651322,0.0003967662,0.2930546],"study_design_scores_gemma":[0.05828087,0.002651541,0.934256,0.00228688,0.000007915256,0.00009137886,0.0002003626,0.00008114364,0.000005710301,0.0003502843,0.00125835,0.0005295311],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9720549,0.02370832,0.00002385608,0.0005317166,0.0003347033,0.001061447,0.00004386666,0.0001967313,0.002044467],"genre_scores_gemma":[0.7299194,0.2675264,0.002175268,0.0001095058,0.00002111392,0.00006997958,0.00003310667,0.00007927042,0.0000659346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2925251,"threshold_uncertainty_score":0.9997779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2118846800","doi":"10.1002/art.20676","title":"Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist","year":2004,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":726,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Western University","funders":"National Center for Research Resources","keywords":"Bosentan; Medicine; Internal medicine; Endothelin receptor antagonist; Scleroderma (fungus); Placebo; Endothelin receptor; Gastroenterology; Clinical endpoint; Surgery; Randomized controlled trial; Receptor; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01613395426366306,"gpt":0.24268793006937,"spread":0.226553975805707,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001175737,0.0002971494,0.0005358604,0.0001258294,0.0001171843,0.0001359562,0.00008386459,0.0001429326,0.0001268635],"category_scores_gemma":[0.00001647101,0.0002307311,0.0001205232,0.0002126903,0.0001124923,0.0004585342,0.00001430796,0.000117007,0.0001483944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005072063,"about_ca_system_score_gemma":0.0002004191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009457787,"about_ca_topic_score_gemma":0.0003593925,"domain_scores_codex":[0.9981176,0.00007291979,0.00060348,0.0004719366,0.0003527237,0.0003813709],"domain_scores_gemma":[0.9991142,0.00002386434,0.0001714281,0.0003526951,0.00004903935,0.0002887493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007116806,0.003409649,0.04958811,0.0001544857,0.0004220968,0.0001393519,0.002352577,0.00009552521,0.06860068,0.0002704513,0.0009291185,0.8733262],"study_design_scores_gemma":[0.253148,0.04092852,0.09850727,0.467586,0.0010074,0.009580377,0.03735141,0.0003980586,0.0822456,0.0008215462,0.003596393,0.004829397],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9681627,0.02937008,0.00009441358,0.0002485709,0.0001879368,0.001042313,0.0002128049,0.0001573464,0.0005238699],"genre_scores_gemma":[0.9645447,0.03393632,0.0002577377,0.00006418268,0.00004028449,0.0001920152,0.000443088,0.00005525833,0.0004664093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8684969,"threshold_uncertainty_score":0.9408941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993216906","doi":"10.1002/art.34593","title":"Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations","year":2012,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"IgG4-Related and Inflammatory Diseases","field":"Medicine","cited_by":726,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases","keywords":"Nomenclature; Organ system; Medicine; Disease; Pathology; Biology; Zoology; Taxonomy (biology)","retraction":null,"screen_n_in":null,"score":{"opus":0.01876704465387163,"gpt":0.2559118217198626,"spread":0.237144777065991,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002481565,0.0001363562,0.0002101786,0.00008898944,0.000316492,0.00002372574,0.00007268193,0.00008733827,0.0002427108],"category_scores_gemma":[0.0001768997,0.0001059831,0.00007646073,0.0001489222,0.0000706343,0.0003120179,0.00003572775,0.0001543606,0.00003031144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002453209,"about_ca_system_score_gemma":0.00008316858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001102294,"about_ca_topic_score_gemma":0.000005165114,"domain_scores_codex":[0.9989682,0.00005215686,0.0004095834,0.0001402735,0.000178136,0.0002516871],"domain_scores_gemma":[0.9989914,0.0002558483,0.0001595874,0.0002074332,0.0001219486,0.0002637964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.0002769115,0.0009787702,0.04870867,0.002291186,0.00194304,0.00006283372,0.01945389,0.00002471961,0.0008615221,0.7449726,0.04787952,0.1325463],"study_design_scores_gemma":[0.01179877,0.0004625811,0.9397597,0.01028751,0.002332307,0.001084849,0.008007732,0.002899671,0.0005166561,0.00263879,0.01935552,0.0008559235],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422023,0.04865068,0.0002438504,0.0046617,0.0006196045,0.001647234,0.001021128,0.0001546233,0.0007988891],"genre_scores_gemma":[0.996116,0.002656604,0.0003013193,0.0001316745,0.0000567602,0.000139923,0.0003604464,0.00002649476,0.0002107255],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.891051,"threshold_uncertainty_score":0.4321865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076417190","doi":"10.1002/art.37754","title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial","year":2012,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Inflammatory Myopathies and Dermatomyositis","field":"Medicine","cited_by":691,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; University of Pittsburgh","keywords":"Rituximab; Medicine; Juvenile dermatomyositis; Polymyositis; Randomized controlled trial; Internal medicine; Placebo; Refractory (planetary science); Clinical endpoint; Dermatomyositis; Muscle weakness; Physical therapy; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.008314454623898833,"gpt":0.262417987214848,"spread":0.2541035325909491,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005875942,0.0003586944,0.00142292,0.000208125,0.0001861724,0.00005893427,0.00007909755,0.0001876293,0.0000907816],"category_scores_gemma":[0.0001822896,0.000263623,0.0002015946,0.0001547796,0.0004394894,0.0004128964,0.00003356335,0.0001936575,0.00001797541],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005887295,"about_ca_system_score_gemma":0.00006418566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001129329,"about_ca_topic_score_gemma":0.0001954653,"domain_scores_codex":[0.9972484,0.0004893119,0.001025053,0.0003019716,0.0003969157,0.0005383298],"domain_scores_gemma":[0.9983063,0.0006481479,0.0002990424,0.0003984791,0.0001089237,0.000239124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3290363,0.007847657,0.006652297,0.0005331243,0.0004551829,0.0009673841,0.06794707,2.659786e-7,0.000356911,0.01678982,0.002847595,0.5665664],"study_design_scores_gemma":[0.9840218,0.001670924,0.003455487,0.001260857,0.0001962788,0.003933592,0.00191159,0.0001959205,0.0006042407,0.0002829638,0.002132691,0.0003336225],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9517105,0.04359228,0.00005913746,0.000980173,0.0002391264,0.002345438,0.00007114808,0.00005094655,0.0009512687],"genre_scores_gemma":[0.9538711,0.04407244,0.0005768476,0.0006387546,0.000156774,0.0005615855,0.00005267738,0.00003530372,0.00003456003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6549855,"threshold_uncertainty_score":0.9999816,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094124191","doi":"10.1002/art.20967","title":"Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)","year":2005,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Center for Research Resources","keywords":"Medicine; Infliximab; Psoriatic arthritis; Internal medicine; Rheumatoid arthritis; Psoriasis; Placebo; Tolerability; Dactylitis; Rheumatology; Randomized controlled trial; Psoriasis Area and Severity Index; Arthritis; Surgery; Physical therapy; Dermatology; Adverse effect; Enthesitis; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01465082786551167,"gpt":0.2733882787557457,"spread":0.258737450890234,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005897207,0.0004902678,0.001646752,0.0001898743,0.000404834,0.00006615295,0.0001699462,0.0002055904,0.0001323289],"category_scores_gemma":[0.002086823,0.0003756665,0.0004737841,0.0002834208,0.0003760135,0.0003453954,0.00009540027,0.0002032461,0.00001001062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008811738,"about_ca_system_score_gemma":0.0002389349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005218541,"about_ca_topic_score_gemma":0.001028225,"domain_scores_codex":[0.9958856,0.0002174126,0.002074682,0.0005573719,0.0006795624,0.0005854385],"domain_scores_gemma":[0.9951168,0.002472302,0.0009808356,0.0005660203,0.0006812985,0.0001826869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.06667179,0.002512907,0.002341704,0.00007082987,0.00228359,0.00008457931,0.006575308,0.0002952085,0.0001738232,0.007183655,0.001520585,0.910286],"study_design_scores_gemma":[0.922106,0.003959555,0.06035936,0.002611996,0.0002822711,0.0003900595,0.00149672,0.00185707,0.0007744478,0.005054014,0.0006137331,0.0004948032],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9009995,0.08837738,0.000168463,0.002869216,0.0002747251,0.005787474,0.001293327,0.00006891647,0.0001610337],"genre_scores_gemma":[0.9392728,0.05403601,0.004430411,0.0002787065,0.0001988632,0.001221359,0.000481043,0.00005173491,0.00002909828],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9097912,"threshold_uncertainty_score":0.9998695,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045317929","doi":"10.1002/art.24403","title":"Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study","year":2009,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":603,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; University of Toronto","funders":"","keywords":"Golimumab; Medicine; Psoriatic arthritis; Placebo; Psoriasis Area and Severity Index; Enthesitis; Psoriasis; Internal medicine; Etanercept; Body surface area; Surgery; Arthritis; Rheumatoid arthritis; Dermatology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01692719679529029,"gpt":0.2831028474384452,"spread":0.2661756506431548,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009233173,0.0007650626,0.004024751,0.0005684669,0.0003905575,0.0001352477,0.0001695648,0.0001972239,0.0001564342],"category_scores_gemma":[0.001668775,0.000712758,0.0005031107,0.0004968127,0.0002403208,0.0003072511,0.0001142184,0.0004446191,0.0000370517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000180999,"about_ca_system_score_gemma":0.00023985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004954498,"about_ca_topic_score_gemma":0.004352992,"domain_scores_codex":[0.9938609,0.0006608111,0.002775314,0.001025863,0.0008356209,0.0008414866],"domain_scores_gemma":[0.9966623,0.001071243,0.0009555727,0.0006924049,0.0001809586,0.0004375089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6154079,0.006137123,0.004978999,0.0001141579,0.002081588,0.0059757,0.01415952,0.00001671808,0.0009053583,0.0002884397,0.0004151589,0.3495193],"study_design_scores_gemma":[0.8734435,0.01720965,0.09654877,0.0059659,0.000421557,0.003284603,0.001188265,0.00008734097,0.00005167352,0.001146019,0.00005023277,0.0006024366],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776316,0.01182339,0.00002510812,0.0005929939,0.0003709117,0.008232434,0.000116733,0.000157148,0.001049639],"genre_scores_gemma":[0.9858972,0.0125478,0.0003600629,0.0001688898,0.00009978923,0.0002566695,0.00008516327,0.00007041288,0.0005139928],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3489169,"threshold_uncertainty_score":0.9995323,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089255535","doi":"10.1002/art.24038","title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","year":2008,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":602,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; University of Calgary; Université de Montréal","funders":"","keywords":"Autoantibody; Medicine; Connective tissue disease; Pathology; Scleroderma (fungus); Immunopathology; Prospective cohort study; Internal medicine; Antibody; Autoimmune disease; Immunology; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02115824707249917,"gpt":0.2447956478835016,"spread":0.2236374008110024,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004104171,0.000316856,0.001035564,0.0002240395,0.0002624718,0.0000291045,0.0001577633,0.0001294683,0.00000595717],"category_scores_gemma":[0.0002045204,0.0002029064,0.0001638892,0.0002759605,0.0002085133,0.0002067193,0.00007595054,0.0001001866,4.715875e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008150491,"about_ca_system_score_gemma":0.0001008025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002387964,"about_ca_topic_score_gemma":0.00001315989,"domain_scores_codex":[0.9973181,0.000165221,0.001024044,0.0005053288,0.000705554,0.0002817924],"domain_scores_gemma":[0.9971041,0.000232057,0.001008333,0.0004641055,0.001064173,0.0001272425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001820538,0.001645371,0.9236584,0.00204228,0.001307,9.326832e-7,0.03401909,0.00005630183,0.03296826,0.00002158917,0.00005740278,0.002402803],"study_design_scores_gemma":[0.01340028,0.006376609,0.8808083,0.058476,0.0005457141,0.00001074863,0.02170281,0.00006307503,0.01841352,0.000006047008,3.065529e-7,0.0001966018],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749372,0.009454462,0.0005663381,0.00001453349,0.0001574422,0.01438029,0.0004392226,0.00004608492,0.000004443171],"genre_scores_gemma":[0.9962495,0.002273799,0.0003332178,0.000003734507,0.0000207418,0.0009951476,0.00005816113,0.00005791339,0.000007800521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05643372,"threshold_uncertainty_score":0.8274285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092773063","doi":"10.1002/art.23969","title":"Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial","year":2008,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":593,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Golimumab; Medicine; Placebo; Ankylosing spondylitis; BASDAI; Randomization; Adverse effect; Internal medicine; Physical therapy; Randomized controlled trial; Etanercept; Rheumatoid arthritis","retraction":null,"screen_n_in":null,"score":{"opus":0.0149329285394413,"gpt":0.2651138677179464,"spread":0.2501809391785051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007086948,0.0003685451,0.002946023,0.0003351601,0.0001643279,0.00001238779,0.00007693127,0.0001311515,0.00009377786],"category_scores_gemma":[0.000450416,0.0002896233,0.0002420466,0.0003267193,0.0006458218,0.0001993437,0.00006633379,0.0001979253,0.000003136834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005905932,"about_ca_system_score_gemma":0.0001227437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001047674,"about_ca_topic_score_gemma":0.0002720426,"domain_scores_codex":[0.9963434,0.0002112095,0.001930789,0.000480793,0.0006051779,0.0004286357],"domain_scores_gemma":[0.9977421,0.0007466522,0.0007120092,0.0003981388,0.0002343627,0.00016679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9690682,0.002530824,0.001709589,0.00004830541,0.0007294095,0.000148522,0.002451032,0.000005019387,0.000008180065,0.0002577105,0.00005083069,0.02299233],"study_design_scores_gemma":[0.9845915,0.004792267,0.00611737,0.003560591,0.0002372158,0.000110379,0.0001482158,0.00002638882,0.00006511046,0.0000423235,0.00007948441,0.0002291089],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981328,0.008883667,0.00002330004,0.00009688015,0.0001458183,0.007364049,0.0003779186,0.00003228491,0.00174811],"genre_scores_gemma":[0.9882279,0.01035238,0.000656898,0.00002142166,0.00003246257,0.0002905536,0.000298046,0.0000370793,0.00008327765],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02276322,"threshold_uncertainty_score":0.9999556,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035320881","doi":"10.1002/art.37816","title":"Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study","year":2013,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":582,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Interim analysis; Janus kinase inhibitor; Rheumatology; Methotrexate; Randomized controlled trial; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01977718972046093,"gpt":0.2746561175317261,"spread":0.2548789278112652,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002913237,0.001179279,0.004025195,0.001198791,0.0005999375,0.0007227575,0.001190425,0.0003092186,0.006649234],"category_scores_gemma":[0.001484862,0.00102178,0.0004194584,0.001420511,0.0009333921,0.002736611,0.0006183642,0.001288464,0.0003972668],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001321853,"about_ca_system_score_gemma":0.0003066489,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02399625,"about_ca_topic_score_gemma":0.009030197,"domain_scores_codex":[0.9889212,0.001931345,0.002816079,0.002131558,0.00227767,0.001922136],"domain_scores_gemma":[0.9929296,0.00151315,0.0008274019,0.00306999,0.0005761643,0.001083741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.03473989,0.007009779,0.2948028,0.00005787346,0.002308362,0.0006247791,0.006927511,0.000008387084,0.0001816125,0.000150803,0.005861791,0.6473264],"study_design_scores_gemma":[0.7864444,0.002962967,0.1918631,0.009716433,0.00004906575,0.0001421096,0.002595712,0.001506173,0.00007489921,0.001307057,0.001824928,0.001513164],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9488355,0.03764984,0.0005486203,0.0005385409,0.000407585,0.01005041,0.0007431863,0.0004170553,0.0008092526],"genre_scores_gemma":[0.8570663,0.1350545,0.003504452,0.0001752779,0.00005967734,0.001606518,0.002233388,0.0002113454,0.00008847655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7517045,"threshold_uncertainty_score":0.9992232,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006566716","doi":"10.1002/art.23964","title":"Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study","year":2008,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":577,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Versus Arthritis","keywords":"Certolizumab pegol; Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Methotrexate; Rheumatology; Randomized controlled trial; Gastroenterology; Arthritis; Surgery; Adalimumab; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02621123664039309,"gpt":0.3207589398457946,"spread":0.2945477032054015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.003010727,0.001779621,0.008123909,0.001923301,0.0008146373,0.000229103,0.0008872364,0.0005100706,0.00131691],"category_scores_gemma":[0.001685643,0.001632145,0.001588794,0.001367796,0.001924241,0.00144262,0.0004413915,0.001966523,0.0001856637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006220266,"about_ca_system_score_gemma":0.0008279243,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01071402,"about_ca_topic_score_gemma":0.003853638,"domain_scores_codex":[0.9851221,0.003629391,0.004075811,0.002217723,0.002541172,0.002413735],"domain_scores_gemma":[0.990429,0.004674085,0.001472908,0.001570277,0.0007232627,0.001130407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8668854,0.005244508,0.001087553,0.0001687495,0.004002376,0.004836075,0.06359959,0.0001562738,0.000990489,0.0005409279,0.0005854979,0.05190261],"study_design_scores_gemma":[0.9614636,0.003738158,0.0009227758,0.006747921,0.0001151211,0.00294412,0.009851005,0.009196728,0.00305861,0.0003882675,0.0001771749,0.001396549],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9167827,0.04952206,0.001977881,0.0006335046,0.0004454975,0.028979,0.0002659462,0.0003371026,0.001056295],"genre_scores_gemma":[0.8252037,0.163467,0.002655552,0.00009168321,0.00006379557,0.00778145,0.0001783895,0.0002472776,0.0003112122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1139449,"threshold_uncertainty_score":0.999596,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2056768892","doi":"10.1002/art.10262","title":"A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis","year":2002,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":576,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Giant cell arteritis; Internal medicine; Methotrexate; Placebo; Prednisone; Multicenter trial; Gastroenterology; Surgery; Randomized controlled trial; Incidence (geometry); Vasculitis; Disease; Multicenter study; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02548312845623854,"gpt":0.2756413263474147,"spread":0.2501581978911762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005359724,0.0003860023,0.002359016,0.0002426945,0.0001904795,0.00004461878,0.0001017276,0.0002242985,0.001667536],"category_scores_gemma":[0.0001567529,0.0002934891,0.001371274,0.0001420879,0.0002146159,0.0001431149,0.00002327514,0.0001743206,0.0001097866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007629326,"about_ca_system_score_gemma":0.00005738671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002450065,"about_ca_topic_score_gemma":0.00006730585,"domain_scores_codex":[0.9970303,0.0002600189,0.001409854,0.0004592495,0.0003428203,0.0004977283],"domain_scores_gemma":[0.9979132,0.0006857656,0.0004684225,0.0004823355,0.0001775186,0.0002727576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8693569,0.002002937,0.000002475668,0.0000833376,0.001258659,0.00008730171,0.001435251,0.00001498456,0.0008605337,0.00082334,0.0009159716,0.1231583],"study_design_scores_gemma":[0.9849861,0.002310937,0.000007600703,0.001202035,0.0009655483,0.0001688209,0.0001388728,0.007355185,0.001198366,0.0003008032,0.001091881,0.000273878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8435478,0.07048623,0.008594815,0.004635197,0.002972414,0.05031156,0.000546088,0.0003555983,0.01855033],"genre_scores_gemma":[0.9227793,0.06201827,0.006072178,0.00008932022,0.0001192952,0.005337638,0.0001522901,0.0000627528,0.003369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1228844,"threshold_uncertainty_score":0.9999517,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075619622","doi":"10.1002/art.22809","title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register","year":2007,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":561,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Arthritis Society","funders":"Versus Arthritis; British Society for Rheumatology; Arthritis Society; University of Manchester; Amgen; Abbott Laboratories","keywords":"Medicine; Rheumatoid arthritis; Rheumatology; Internal medicine; Cohort; Incidence (geometry); Myocardial infarction; Rate ratio; Confidence interval; Cohort study; Prospective cohort study; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01416150645334343,"gpt":0.2553101543683637,"spread":0.2411486479150202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002413879,0.0003758129,0.0009759712,0.0002120329,0.0005011857,0.000257096,0.0004454941,0.0002457835,0.00004158433],"category_scores_gemma":[0.001212013,0.0002788966,0.0003397443,0.0009039226,0.0006454043,0.0004659399,0.00009787412,0.0006055992,0.00000934506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001228552,"about_ca_system_score_gemma":0.0002024601,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01454425,"about_ca_topic_score_gemma":0.01264707,"domain_scores_codex":[0.9956118,0.0003891403,0.001505007,0.0007604992,0.0008414719,0.0008920472],"domain_scores_gemma":[0.9967224,0.001442873,0.0004676844,0.0007833238,0.0004188123,0.0001649301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007780134,0.0006584469,0.5093194,0.00003677394,0.0003043446,0.00003868207,0.02031474,0.00001823194,0.001246776,0.0003810567,0.009288788,0.4506126],"study_design_scores_gemma":[0.01792455,0.001639177,0.9657916,0.005450574,0.000002838123,0.0002454058,0.002241776,0.00002496184,0.0003781835,0.0008563704,0.005079097,0.0003654209],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838268,0.00938952,0.0003498876,0.002485052,0.0002887289,0.003012758,0.0005215555,0.00005423985,0.00007146555],"genre_scores_gemma":[0.898963,0.09861913,0.00118378,0.0006579381,0.0000369954,0.0002380963,0.0002360061,0.00005002605,0.00001496527],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4564722,"threshold_uncertainty_score":0.9999663,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982569518","doi":"10.1002/art.23204","title":"Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus","year":2008,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":556,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Toronto Western Hospital","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Rheumatology; Cohort; Internal medicine; Age of onset; Systemic lupus erythematosus; Incidence (geometry); Lupus erythematosus; Systemic disease; Young adult; Prospective cohort study; Connective tissue disease; Cohort study; Pediatrics; Disease; Autoimmune disease; Immunology; Antibody","retraction":null,"screen_n_in":null,"score":{"opus":0.01365900133248969,"gpt":0.2535172639889806,"spread":0.2398582626564909,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003889585,0.000462907,0.001145006,0.0004608235,0.0002715554,0.00006437279,0.000272391,0.000222105,0.00008512111],"category_scores_gemma":[0.0008245025,0.0004159139,0.0001448263,0.0004415179,0.0004157799,0.0001882077,0.0001973192,0.0006030669,0.0001511095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001576362,"about_ca_system_score_gemma":0.000324493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005161313,"about_ca_topic_score_gemma":0.0002057068,"domain_scores_codex":[0.9962305,0.00029918,0.0009058987,0.0007796198,0.000929258,0.0008555808],"domain_scores_gemma":[0.9974457,0.0005290739,0.0001878738,0.0008817239,0.0001577091,0.0007979312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001043541,0.0001600142,0.9796293,0.0007500777,0.00007135292,0.001276665,0.006244927,5.332104e-7,0.00004268089,0.0001757518,0.002893094,0.008651288],"study_design_scores_gemma":[0.005649033,0.0001483973,0.8260145,0.01294065,0.00002751099,0.1533121,0.0007389294,0.00003780322,0.00003207322,0.0006904469,0.00003964325,0.0003689002],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663901,0.03050281,0.00003999465,0.0007096507,0.0002198707,0.001459044,0.000199741,0.0001950366,0.0002837482],"genre_scores_gemma":[0.9760868,0.02204748,0.0002652045,0.0001367669,0.00008630376,0.0002517999,0.0001533922,0.00008403776,0.0008882202],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1536148,"threshold_uncertainty_score":0.9998293,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2164229113","doi":"10.1002/1529-0131(200101)44:1<202::aid-anr27>3.0.co;2-w","title":"Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial","year":2001,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":550,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"National Center for Research Resources","keywords":"Medicine; Bone mineral; Femoral neck; Placebo; Trochanter; Bone remodeling; Osteoporosis; Alendronic acid; Urology; Bone density; Greater trochanter; Internal medicine; Osteopenia; Vitamin D and neurology; Randomized controlled trial; Surgery; Femur","retraction":null,"screen_n_in":null,"score":{"opus":0.01180156079439284,"gpt":0.282363124287018,"spread":0.2705615634926252,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001297966,0.0002979052,0.001874947,0.0003766912,0.000118537,0.00003187844,0.00006788041,0.0002227654,0.00008982522],"category_scores_gemma":[0.001649081,0.0002438515,0.0002103963,0.0002430981,0.0001704911,0.0001831384,0.00006530961,0.0005695121,0.00002331465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008077818,"about_ca_system_score_gemma":0.0001300461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001270975,"about_ca_topic_score_gemma":0.0006922018,"domain_scores_codex":[0.9965749,0.0005050328,0.001078879,0.0004856566,0.0007491445,0.0006063199],"domain_scores_gemma":[0.9977457,0.001043616,0.0003065616,0.0003622893,0.0001855391,0.0003563015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9481994,0.0006976292,0.01077601,0.0001846503,0.00006596962,0.0001607236,0.0004196873,0.000005010524,0.0002908382,0.00009574169,0.0002271298,0.03887725],"study_design_scores_gemma":[0.9375814,0.002050658,0.05652235,0.002653906,0.00005534852,0.00006140576,0.00003767398,0.0004108296,0.0002802728,0.0001432246,0.00001509718,0.0001878902],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883043,0.002859453,0.00001423353,0.0005502302,0.0003464695,0.007426484,0.000002482422,0.00003814809,0.0004581627],"genre_scores_gemma":[0.9925285,0.006133602,0.0002756092,0.0004196918,0.00007217486,0.0003751593,0.00004598087,0.00003690147,0.0001123614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04574635,"threshold_uncertainty_score":0.9943976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017638669","doi":"10.1002/art.10777","title":"Safety and efficacy of long‐term intraarticular steroid injections in osteoarthritis of the knee: A randomized, double‐blind, placebo‐controlled trial","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":537,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôtel-Dieu de Québec; Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Hôpital Notre-Dame","funders":"","keywords":"WOMAC; Medicine; Osteoarthritis; Triamcinolone acetonide; Range of motion; Placebo; Randomized controlled trial; Knee pain; Physical therapy; Arthropathy; McGill Pain Questionnaire; Knee Joint; Surgery; Visual analogue scale","retraction":null,"screen_n_in":null,"score":{"opus":0.01040715329766883,"gpt":0.2485412471483611,"spread":0.2381340938506923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001074143,0.0003372965,0.001902292,0.0002653691,0.000139403,0.00003072035,0.00009879688,0.0002031082,0.0002355173],"category_scores_gemma":[0.0006133917,0.0002560352,0.0004779637,0.000385315,0.00045091,0.0001861882,0.00006027982,0.0002986716,0.000007585078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000494765,"about_ca_system_score_gemma":0.0001757336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001264003,"about_ca_topic_score_gemma":0.001003096,"domain_scores_codex":[0.996645,0.0005867439,0.001521281,0.0003926606,0.0004488609,0.0004054373],"domain_scores_gemma":[0.9981173,0.0006043905,0.0004614163,0.0005354544,0.0001207475,0.0001606884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8991021,0.0007102339,0.0009028914,0.00006331177,0.0002179713,0.00004894942,0.001329186,0.000005976661,0.001217129,0.006865346,0.000007301895,0.08952961],"study_design_scores_gemma":[0.987691,0.00263161,0.001032707,0.002336913,0.0002793009,0.0003793119,0.000155929,0.000009287315,0.004788418,0.0004638819,0.00002764492,0.0002039473],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751609,0.01171967,0.0001246208,0.0001670353,0.0006365545,0.01007292,0.00002201268,0.00003575235,0.002060557],"genre_scores_gemma":[0.9950786,0.003452461,0.000366267,0.00003971412,0.00003407979,0.000668361,0.00002031394,0.00003847142,0.0003017149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08932567,"threshold_uncertainty_score":0.9999892,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012059967","doi":"10.1002/1529-0131(200001)43:1<22::aid-anr4>3.0.co;2-9","title":"Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration","year":2000,"lang":"en","type":"review","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":511,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Clinical trial; Methotrexate; Rheumatology; Disease; Randomized controlled trial; Arthritis; Physical therapy; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03189688857837315,"gpt":0.3146129079098421,"spread":0.2827160193314689,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001084868,0.0008806123,0.003020844,0.0007481894,0.0002925957,0.0001290087,0.0003956051,0.0002728186,0.001004224],"category_scores_gemma":[0.001099957,0.0006072232,0.000800624,0.0009135854,0.000307976,0.0003094315,0.0001047118,0.0005746124,0.0001349081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000398294,"about_ca_system_score_gemma":0.001374997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000443261,"about_ca_topic_score_gemma":0.001745876,"domain_scores_codex":[0.9937339,0.0010205,0.002509925,0.0008752448,0.0009439751,0.0009164448],"domain_scores_gemma":[0.9960786,0.001199622,0.000622183,0.001297976,0.0001164212,0.0006852513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005590453,0.0003026835,0.004146214,0.0008328221,0.0002250679,0.0001796643,0.001682741,0.000003496606,0.000002266714,0.0001461142,0.000303413,0.9916165],"study_design_scores_gemma":[0.003377955,0.001309838,0.008818503,0.1665043,0.00003100551,0.0002530111,0.0003727157,0.00001928969,0.00001025177,0.0002319823,0.8184037,0.0006674933],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1281682,0.8666747,0.000006849841,0.0003925683,0.0001627872,0.003851719,0.0004406036,0.0001108838,0.00019178],"genre_scores_gemma":[0.04194513,0.9558722,0.00009061208,0.00004690349,0.00004400722,0.001298141,0.0003775933,0.0001455902,0.0001798106],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.990949,"threshold_uncertainty_score":0.999909,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114426847","doi":"10.1002/1529-0131(200111)44:11<2531::aid-art433>3.0.co;2-j","title":"Effects of a ginger extract on knee pain in patients with osteoarthritis","year":2001,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Ginger and Zingiberaceae research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":508,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Osteoarthritis; Medicine; Placebo; Visual analogue scale; Knee pain; Acetaminophen; Zingiber officinale; Randomized controlled trial; Knee Joint; Anesthesia; Internal medicine; Surgery; Traditional medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02475693780270133,"gpt":0.3390182136398739,"spread":0.3142612758371726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001046281,0.0002642104,0.0004338571,0.0003163615,0.0001473546,0.00002535851,0.0001896015,0.0002262849,0.001004593],"category_scores_gemma":[0.0002580189,0.000251593,0.00007751784,0.0004080548,0.0001878026,0.000211961,0.0000531224,0.0007965153,0.0001409385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005981125,"about_ca_system_score_gemma":0.000054927,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009754899,"about_ca_topic_score_gemma":0.000174627,"domain_scores_codex":[0.9973015,0.000796142,0.0004456636,0.0003703078,0.000395516,0.0006908249],"domain_scores_gemma":[0.9979888,0.001334416,0.0001329893,0.0002315653,0.0001009937,0.0002112093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0005536544,0.0008147738,0.2498032,0.00008432818,0.00004915034,0.0001966899,0.0006701976,0.00007004676,0.000600591,0.0002547792,0.0006738576,0.7462288],"study_design_scores_gemma":[0.02787412,0.006419446,0.9351796,0.003080439,0.0000343048,0.00004304218,0.000082689,0.0004051339,0.005182486,0.0007285984,0.0202023,0.0007678432],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918861,0.003610502,0.00006231263,0.000197462,0.0002876577,0.0008921613,0.00001870577,0.00006132603,0.002983795],"genre_scores_gemma":[0.9969901,0.002019013,0.0001748688,0.0003733635,0.00003420786,0.0001400437,0.00002411559,0.00004212824,0.0002021897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7454609,"threshold_uncertainty_score":0.9999936,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053342448","doi":"10.1002/art.20776","title":"Role of interleukin‐1 and tumor necrosis factor α in matrix degradation of human osteoarthritic cartilage","year":2005,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":505,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; Montreal General Hospital; Shriners Hospitals for Children - Canada","funders":"","keywords":"Aggrecan; Cartilage; Aggrecanase; Tumor necrosis factor alpha; Collagenase; Matrix metalloproteinase; Type II collagen; Chemistry; Interleukin; Proteoglycan; Molecular biology; Glycosaminoglycan; Medicine; Immunology; Cytokine; Internal medicine; Endocrinology; Pathology; Osteoarthritis; Biology; Biochemistry; Anatomy; Articular cartilage; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.008926208202618177,"gpt":0.2510988475273744,"spread":0.2421726393247562,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001318808,0.0002189299,0.0006317964,0.0002819311,0.00005343686,0.0000183687,0.00007122537,0.00009428166,0.0002890106],"category_scores_gemma":[0.00005954674,0.0002286044,0.0001038404,0.0001730679,0.0001326035,0.0002988748,0.00005136325,0.00012948,0.00001709422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005336225,"about_ca_system_score_gemma":0.0000535796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002702471,"about_ca_topic_score_gemma":0.003289396,"domain_scores_codex":[0.9983457,0.0000541775,0.0007477072,0.0002886857,0.0002685945,0.0002951913],"domain_scores_gemma":[0.9992239,0.00007313237,0.0002142334,0.0002793909,0.00007948103,0.0001298241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006063302,0.0002411932,0.02813897,0.0001159822,0.00001407921,0.00002253875,0.002003917,6.881953e-7,0.6534934,0.00288066,0.00001520199,0.3130127],"study_design_scores_gemma":[0.01642727,0.004984634,0.06258705,0.007558699,0.0000768749,0.0003616405,0.001631055,0.00007550634,0.9034684,0.00214897,0.0002197031,0.0004601642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896871,0.008814109,0.000007029026,0.000106418,0.00005174817,0.0005794609,0.00006666095,0.00004187162,0.0006455851],"genre_scores_gemma":[0.9970039,0.0009918982,0.00160264,0.00003416084,0.00002154727,0.00004900478,0.00005710315,0.00003340769,0.0002063741],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3125526,"threshold_uncertainty_score":0.9322218,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2081651663","doi":"10.1002/art.11420","title":"Physical functioning over three years in knee osteoarthritis: Role of psychosocial, local mechanical, and neuromuscular factors","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":491,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"WOMAC; Physical therapy; Psychosocial; Osteoarthritis; Medicine; Rehabilitation; Physical medicine and rehabilitation; Visual analogue scale; Body mass index; Logistic regression; Hamstring; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.007662749347415663,"gpt":0.2265070765084119,"spread":0.2188443271609962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001718049,0.00029218,0.0006903911,0.0001792458,0.00009585525,0.00003557013,0.00005954247,0.0001781459,0.0002474629],"category_scores_gemma":[0.0000977978,0.0003125812,0.0001835103,0.0002815246,0.0001785575,0.0002476218,0.00004147434,0.0002938532,0.00002468026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004524185,"about_ca_system_score_gemma":0.00006910825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002042941,"about_ca_topic_score_gemma":0.0008705352,"domain_scores_codex":[0.998084,0.0001049571,0.0004715612,0.000479002,0.0004194834,0.0004409819],"domain_scores_gemma":[0.9991816,0.0001051236,0.0001268433,0.0003259623,0.00004919297,0.0002112894],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001332998,0.0006975204,0.03107144,0.00005381729,0.00008410191,0.0001807533,0.001682011,0.000006037834,0.02638562,0.03599677,0.00006083649,0.9036478],"study_design_scores_gemma":[0.1034135,0.03750039,0.6180856,0.01288857,0.0006209713,0.001498822,0.01010078,0.0007897885,0.06254555,0.1395162,0.009696083,0.003343744],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907063,0.007096767,0.0001925353,0.00003670386,0.000285159,0.0006268737,0.00001853527,0.00007521295,0.0009618813],"genre_scores_gemma":[0.9983041,0.0008340616,0.0005889172,0.00005916652,0.00003449797,0.00006492554,0.0000268343,0.00005709275,0.00003035061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.900304,"threshold_uncertainty_score":0.9999326,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1621490964","doi":"10.1002/art.38070","title":"The Impact of Tumor Necrosis Factor α Inhibitors on Radiographic Progression in Ankylosing Spondylitis","year":2013,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":488,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"National Center for Research Resources; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Ankylosing spondylitis; Internal medicine; Odds ratio; Erythrocyte sedimentation rate; Confidence interval; Spondylitis; Hazard ratio; Confounding; Surgery; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.01059353475045043,"gpt":0.2773847008184724,"spread":0.2667911660680219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001547671,0.0003061205,0.0005825186,0.000266766,0.0002865176,0.00007656704,0.0001045961,0.00008348579,0.0005397564],"category_scores_gemma":[0.0001482676,0.000197611,0.0003379075,0.0005300863,0.0002717221,0.0002184325,0.00005943934,0.0002389335,0.00006028914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001304687,"about_ca_system_score_gemma":0.00006312354,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004628764,"about_ca_topic_score_gemma":0.0003489221,"domain_scores_codex":[0.9979359,0.00009460212,0.0006434487,0.0003435416,0.0004117919,0.0005707458],"domain_scores_gemma":[0.9988298,0.0002399164,0.0002206653,0.000417816,0.0001134885,0.000178246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001936019,0.0004739388,0.4178938,0.00002941815,0.0001681519,0.0001200205,0.000796678,0.000002220795,0.001550649,0.0002327033,0.001650502,0.5768883],"study_design_scores_gemma":[0.005233721,0.002243088,0.9843307,0.005074265,0.00001292411,0.0001704426,0.000217074,0.00006089608,0.001417744,0.0007740298,0.0002554995,0.0002096554],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846191,0.0126028,0.000001290582,0.000393826,0.0002057675,0.001234018,0.0001116547,0.00005506642,0.0007764469],"genre_scores_gemma":[0.9902561,0.009086835,0.0002082615,0.00003946344,0.00003517437,0.0002479998,0.00004022116,0.00004054702,0.00004544465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5766786,"threshold_uncertainty_score":0.8058343,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026404803","doi":"10.1002/art.30128","title":"Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series","year":2010,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":464,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Anakinra; Medicine; Internal medicine; Arthritis; Rash; Adverse effect; Discontinuation; Etanercept; Concomitant; Surgery; Gastroenterology; Disease; Rheumatoid arthritis","retraction":null,"screen_n_in":null,"score":{"opus":0.01264805168740381,"gpt":0.2812307048554297,"spread":0.2685826531680259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005173616,0.0002606859,0.0007068759,0.000261744,0.0001274398,0.00006367321,0.0002811379,0.0001664434,0.0008029169],"category_scores_gemma":[0.0005777986,0.0002594832,0.0001476433,0.0001592898,0.0001716316,0.000991202,0.0001077977,0.0005068843,0.00005443337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000607238,"about_ca_system_score_gemma":0.000257162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002186734,"about_ca_topic_score_gemma":0.002850873,"domain_scores_codex":[0.9968638,0.00009267845,0.001408429,0.0004944575,0.0007531868,0.0003874224],"domain_scores_gemma":[0.9982153,0.00005182467,0.000434273,0.0007432185,0.0003329674,0.0002224724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005978621,0.0008034923,0.7951024,0.0001177765,0.00008623448,0.000767194,0.001841015,0.00001477853,0.003241526,0.0002327743,0.00007850402,0.1971165],"study_design_scores_gemma":[0.01362268,0.0008098208,0.9692526,0.007911592,0.00001351066,0.0003151572,0.0005256907,0.0009511793,0.001453175,0.0009369231,0.00378318,0.0004244949],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906766,0.006691494,0.00004736008,0.0004884453,0.0006848908,0.0008631441,0.0001113277,0.00007649921,0.0003601811],"genre_scores_gemma":[0.9806491,0.0179522,0.0002854301,0.0001112114,0.00007959403,0.0001784045,0.0005948566,0.00005386558,0.00009531568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.196692,"threshold_uncertainty_score":0.9999858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996437423","doi":"10.1002/art.21678","title":"Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial","year":2006,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":439,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Infliximab; Methotrexate; Rheumatoid arthritis; Erythrocyte sedimentation rate; Internal medicine; Gastroenterology; Concomitant; Placebo; Arthritis; C-reactive protein; Surgery; Tumor necrosis factor alpha; Inflammation; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01116440310405476,"gpt":0.2265330736135078,"spread":0.215368670509453,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007842311,0.000769137,0.0019033,0.0003513003,0.0003079024,0.0002015098,0.0003654053,0.000225457,0.0002974428],"category_scores_gemma":[0.0003273479,0.0004321936,0.0001428098,0.000923652,0.001215142,0.0007202431,0.0001046022,0.000749193,0.00002648938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001233698,"about_ca_system_score_gemma":0.0005115984,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0351881,"about_ca_topic_score_gemma":0.03564058,"domain_scores_codex":[0.9938341,0.0006068712,0.001814321,0.0009726369,0.001740702,0.001031365],"domain_scores_gemma":[0.9962841,0.000719764,0.0008492548,0.001246766,0.0005423722,0.0003577885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2047413,0.001614079,0.7497675,0.00003640735,0.0008148886,0.0005442686,0.002967329,0.00004796694,0.0002152933,0.0004034774,0.0009329036,0.03791459],"study_design_scores_gemma":[0.2861853,0.01217452,0.6888044,0.01028155,0.00002125287,0.0000762581,0.0003990725,0.00005934712,0.0008781012,0.0001357944,0.0004421881,0.0005422015],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904998,0.003179899,0.00004728977,0.0004067556,0.0001051532,0.003871521,0.0008866725,0.0001963675,0.0008065568],"genre_scores_gemma":[0.9848208,0.01123084,0.002432415,0.0000673352,0.00006364579,0.0003470435,0.0007094988,0.0001647929,0.0001636283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08144405,"threshold_uncertainty_score":0.999813,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045012562","doi":"10.1002/art.10954","title":"Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: A placebo‐controlled trial","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Shoulder Injury and Treatment","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph's Hospital; Sunnybrook Health Science Centre; Toronto Western Hospital; Southlake Regional Health Center; Health Sciences Centre; Credit Valley Hospital; Université Laval; University Health Network","funders":"","keywords":"Capsulitis; Medicine; Placebo; Triamcinolone acetonide; Physical therapy; Range of motion; Corticosteroid; Randomized controlled trial; Saline; Surgery; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.01857185201384351,"gpt":0.2987183947460624,"spread":0.280146542732219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002976999,0.0002184539,0.0007896781,0.0000617241,0.00009010331,0.00001128031,0.000160017,0.00007179992,0.0001804483],"category_scores_gemma":[0.000204548,0.00009811143,0.0003746329,0.0003309208,0.0002382641,0.00006408378,0.00001347335,0.00009870256,0.00000128592],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007680674,"about_ca_system_score_gemma":0.0001887894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006488906,"about_ca_topic_score_gemma":0.0008189709,"domain_scores_codex":[0.9975287,0.0007284353,0.0008268839,0.0002075046,0.0004892973,0.0002192297],"domain_scores_gemma":[0.9983406,0.0004883527,0.0003650504,0.0006633862,0.0001035911,0.00003901203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2997994,0.05381213,0.04161258,0.0005948494,0.005811154,0.0001929371,0.1367795,0.0002765322,0.07870161,0.03746633,0.0008744123,0.3440785],"study_design_scores_gemma":[0.830404,0.009419832,0.03077255,0.001339795,0.0006576513,0.00013497,0.002578116,0.0002605089,0.1215184,0.002521238,0.0001911948,0.0002017352],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896316,0.003076253,0.00001986457,0.0009734708,0.000257628,0.005632323,0.00002638851,0.000008734947,0.000373741],"genre_scores_gemma":[0.9968325,0.002167395,0.00008214398,0.0001430908,0.00001507801,0.0006382735,0.000006113349,0.00001840066,0.00009702439],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5306046,"threshold_uncertainty_score":0.4000868,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015271294","doi":"10.1002/art.10631","title":"Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee","year":2002,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":433,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University; University of Toronto","funders":"Canadian Arthritis Network; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Canadian Orthopaedic Foundation; Arthritis Foundation","keywords":"Medicine; Osteoarthritis; WOMAC; Physical therapy; Knee replacement; Prospective cohort study; Joint replacement; Orthopedic surgery; Total hip replacement; Cohort study; Cohort; Hip surgery; Arthroplasty; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02361200788022097,"gpt":0.2549497229805068,"spread":0.2313377151002858,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003501294,0.000335517,0.001136951,0.0001264059,0.000128162,0.00001859358,0.0001296046,0.0001471375,0.001624943],"category_scores_gemma":[0.0008072394,0.0002111626,0.0003774592,0.0002898248,0.0006401653,0.000189963,0.0001994378,0.0003340014,0.00004902363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004806113,"about_ca_system_score_gemma":0.00005767369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001613058,"about_ca_topic_score_gemma":0.00041211,"domain_scores_codex":[0.9967838,0.0001861262,0.001239954,0.000438078,0.0009057859,0.0004462596],"domain_scores_gemma":[0.9975665,0.0004530236,0.0006876538,0.0009142954,0.0001723092,0.0002061721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001739374,0.0005000021,0.8541405,0.0001037436,0.000170465,0.0000227336,0.0006518723,0.000007689277,0.00003136141,0.00005520614,0.00112078,0.1430217],"study_design_scores_gemma":[0.01411855,0.0038038,0.9772817,0.003500595,0.00007866384,0.0000928464,0.0001611577,0.0001021019,0.0005201124,0.00001293757,0.00008722191,0.0002402505],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957226,0.0006421934,0.00002275407,0.0003804729,0.0006092751,0.001410606,0.0000469174,0.00006927588,0.001095896],"genre_scores_gemma":[0.9968337,0.0002374987,0.001366102,0.0001612758,0.00002461943,0.0000481578,0.000009531115,0.00005910011,0.001260011],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1427815,"threshold_uncertainty_score":0.9992877,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2060309556","doi":"10.1002/1529-0131(200106)44:6<1351::aid-art227>3.0.co;2-i","title":"A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma","year":2001,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":429,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal University Hospital; University of Saskatchewan; McMaster University; Jewish General Hospital; University of Ottawa; University of Toronto; University of Manitoba; Western University","funders":"","keywords":"Medicine; DLCO; Placebo; Methotrexate; Internal medicine; Scleroderma (fungus); Diffusing capacity; Randomized controlled trial; Gastroenterology; Surgery; Pathology; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.02298852018863304,"gpt":0.2716792081032395,"spread":0.2486906879146064,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001425029,0.0002556815,0.002473994,0.0002926333,0.00005328145,0.00002856716,0.0001105948,0.0001952671,0.0003420614],"category_scores_gemma":[0.00170015,0.0001924196,0.0006218337,0.0002964577,0.0002000187,0.0001303114,0.00003416675,0.000210403,0.00006273472],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004360841,"about_ca_system_score_gemma":0.000105949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008641146,"about_ca_topic_score_gemma":0.00007824489,"domain_scores_codex":[0.9966351,0.0007239894,0.001464051,0.0003218107,0.0004971203,0.0003579253],"domain_scores_gemma":[0.9971822,0.001687765,0.0004335566,0.0003935396,0.000102105,0.0002008412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9729588,0.0006328122,0.0007672773,0.00002561971,0.0004534316,0.00007397943,0.0007895143,0.000009027041,0.0002904359,0.0004203484,0.0002026303,0.02337611],"study_design_scores_gemma":[0.9896443,0.0004568208,0.002387514,0.006039698,0.0002392733,0.00005157117,0.0001479432,0.0005988704,0.00007380822,0.0001543745,0.00002831557,0.0001775064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9621218,0.02491955,0.0000564605,0.0003138558,0.0009437772,0.004980086,0.000006016918,0.00006990567,0.006588485],"genre_scores_gemma":[0.9408773,0.05777038,0.0001930489,0.00005545718,0.00007445625,0.0006616731,0.00001080556,0.00003227184,0.0003246066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03285083,"threshold_uncertainty_score":0.7846645,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050154180","doi":"10.1002/art.10302","title":"The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double‐blind, placebo‐controlled trial","year":2002,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":423,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Infliximab; Medicine; Rheumatoid arthritis; Internal medicine; Placebo; Gastroenterology; Dosing; Rheumatology; Pharmacokinetics; Randomized controlled trial; Arthritis; Concomitant; Surgery; Tumor necrosis factor alpha; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.04851856605497851,"gpt":0.3265072584249003,"spread":0.2779886923699218,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004589791,0.0004809558,0.00232034,0.0003298048,0.0005104312,0.0002548798,0.000401231,0.0002896316,0.0005906514],"category_scores_gemma":[0.009649673,0.0003788803,0.0007131817,0.0004829773,0.0007873187,0.000472586,0.0001433236,0.0009441137,0.0002766068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001075048,"about_ca_system_score_gemma":0.0002368441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001517707,"about_ca_topic_score_gemma":0.005534943,"domain_scores_codex":[0.991146,0.001219143,0.004727218,0.0008034023,0.001142194,0.0009620517],"domain_scores_gemma":[0.9873226,0.009809822,0.0008856885,0.001051392,0.0003541712,0.0005763145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8326428,0.001117476,0.002803882,0.00001007737,0.0004583146,0.00004146608,0.002811062,0.00002542166,0.00005701996,0.002546869,0.00134127,0.1561444],"study_design_scores_gemma":[0.9861898,0.001212612,0.003013027,0.003439928,0.00001409908,0.00002770081,0.0007564641,0.002260251,0.0001358974,0.001036486,0.001568613,0.0003450931],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9397721,0.03762382,0.0001508482,0.005665463,0.001081088,0.01350399,0.0002396994,0.0001143079,0.00184863],"genre_scores_gemma":[0.7891485,0.2074234,0.0006918934,0.0001757613,0.0001135399,0.002017849,0.0000737204,0.00004921654,0.0003061156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1697996,"threshold_uncertainty_score":0.9998663,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106574491","doi":"10.1002/art.34400","title":"Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus","year":2012,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":416,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources","keywords":"Belimumab; Medicine; Immunology; B-cell activating factor; Autoantibody; Antibody; Internal medicine; Lupus erythematosus; B cell; Systemic lupus erythematosus; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02617818216779881,"gpt":0.2780821484253616,"spread":0.2519039662575627,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006754081,0.0004108248,0.0008817352,0.0004333677,0.0002871403,0.00008946785,0.0001716114,0.000138345,0.0001815618],"category_scores_gemma":[0.00009842573,0.000345085,0.00006944798,0.0004517078,0.0001797534,0.0005522993,0.0001399891,0.0003126819,0.00007225294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002766503,"about_ca_system_score_gemma":0.0001674141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004719462,"about_ca_topic_score_gemma":0.0002472082,"domain_scores_codex":[0.9963086,0.0002372226,0.0009772034,0.0004922375,0.0009519272,0.001032791],"domain_scores_gemma":[0.9984415,0.0001588468,0.000304767,0.0004770373,0.0002369132,0.0003810027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001328439,0.0005429633,0.9829966,0.0009143528,0.00008131151,0.00001924283,0.006208906,0.000006354336,0.000709457,0.0004349785,0.001416451,0.006536575],"study_design_scores_gemma":[0.03428231,0.001632753,0.8862174,0.03993209,0.0001382254,0.02421025,0.007067281,0.0003683704,0.004052943,0.0001943497,0.000420423,0.001483662],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756371,0.0209109,0.0000424432,0.0001618204,0.000476435,0.001842248,0.00008596014,0.0001307986,0.0007123454],"genre_scores_gemma":[0.9957281,0.001372206,0.002065076,0.00003022501,0.00006459266,0.0001770416,0.0001743827,0.00008340524,0.0003049759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09677923,"threshold_uncertainty_score":0.9999001,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968958817","doi":"10.1002/art.20253","title":"Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double‐blind, randomized, placebo‐controlled clinical trial","year":2004,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Leflunomide; Medicine; Psoriatic arthritis; Psoriasis; Double blind; Placebo; Dermatology; Randomized controlled trial; Clinical trial; Arthritis; Placebo-controlled study; Internal medicine; Alternative medicine; Rheumatoid arthritis; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03674986616896051,"gpt":0.3457766156509602,"spread":0.3090267494819997,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002868077,0.0002344813,0.002070236,0.000226294,0.0001078878,0.00003037879,0.0001029925,0.0001598184,0.00006842696],"category_scores_gemma":[0.00121813,0.0001610862,0.0003040347,0.0001803586,0.0006538059,0.000148429,0.00003193393,0.0002071278,0.000005858838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003960667,"about_ca_system_score_gemma":0.0002806531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005601181,"about_ca_topic_score_gemma":0.0003112749,"domain_scores_codex":[0.9962274,0.0005899715,0.002124034,0.0003244778,0.000462107,0.0002720265],"domain_scores_gemma":[0.9965744,0.00241318,0.0004627485,0.000341506,0.000116036,0.00009210295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6659251,0.00134008,0.000215239,0.00004212097,0.0003164185,0.00001925585,0.003278379,0.00001722265,0.00001343388,0.003391613,0.00001569774,0.3254255],"study_design_scores_gemma":[0.9860163,0.002864521,0.007311642,0.001318409,0.000110962,0.00005433158,0.0006229909,0.0001584624,0.00004714959,0.001136152,0.0002314865,0.0001276391],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9460933,0.04501867,0.00007161529,0.001196387,0.0001311274,0.006923012,0.000009942597,0.00001538752,0.0005405569],"genre_scores_gemma":[0.8237253,0.1751123,0.0004485965,0.00003884758,0.00005023315,0.0005525479,0.00002027171,0.00001608385,0.00003580682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3252978,"threshold_uncertainty_score":0.6568903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987733166","doi":"10.1002/art.22838","title":"A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis","year":2007,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Infliximab; Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Methotrexate; Randomized controlled trial; Adverse effect; Rheumatology; Gastroenterology; Arthritis; Juvenile rheumatoid arthritis; Surgery; Tumor necrosis factor alpha; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01794226992777407,"gpt":0.3076366591402672,"spread":0.2896943892124931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00388153,0.000382428,0.003109407,0.0002448637,0.000235119,0.00003063175,0.0002069381,0.0001942256,0.000428829],"category_scores_gemma":[0.001189656,0.0002576933,0.001279775,0.0002828875,0.0007428618,0.000165434,0.00004257682,0.000177247,0.00002223085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008558318,"about_ca_system_score_gemma":0.0005326613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006054214,"about_ca_topic_score_gemma":0.0002811491,"domain_scores_codex":[0.995463,0.0003623388,0.002376304,0.0003668245,0.0007383748,0.0006931801],"domain_scores_gemma":[0.9943475,0.00350082,0.0008333527,0.0007848692,0.0003574295,0.0001760923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6806737,0.0009733918,0.00003007773,0.00006067746,0.001223572,0.00002421317,0.002617972,0.00002898811,0.0006342911,0.002145353,0.0003245958,0.3112632],"study_design_scores_gemma":[0.9812716,0.002918878,0.0001776561,0.0009071625,0.0002121167,0.00007904047,0.0009479428,0.002012101,0.006124405,0.0005936995,0.004530963,0.000224458],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8278793,0.1453664,0.0068343,0.001031172,0.0005219516,0.01644436,0.00004385014,0.00008130965,0.001797349],"genre_scores_gemma":[0.8864083,0.1091734,0.001516969,0.00004844909,0.00006250919,0.002088243,0.00003164552,0.00005915045,0.0006113675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3110387,"threshold_uncertainty_score":0.9999875,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975501001","doi":"10.1002/art.10870","title":"Anakinra, a recombinant human interleukin‐1 receptor antagonist (r‐metHuIL‐1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo‐controlled trial","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint Paul University","funders":"","keywords":"Anakinra; Medicine; Placebo; Adverse effect; Discontinuation; Rheumatoid arthritis; Internal medicine; Placebo-controlled study; Population; Disease; Double blind; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.008667948685326339,"gpt":0.2612080628427256,"spread":0.2525401141573992,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001478406,0.0007526992,0.001858276,0.0008534016,0.0005083818,0.0003759338,0.0004541835,0.0002727472,0.0033396],"category_scores_gemma":[0.001096736,0.0006756783,0.0003874878,0.0005286452,0.0003846085,0.0008424429,0.0001422368,0.0009270923,0.0002838993],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003202208,"about_ca_system_score_gemma":0.0003026959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004803859,"about_ca_topic_score_gemma":0.002695961,"domain_scores_codex":[0.9934289,0.0007397339,0.001929736,0.00108818,0.001371663,0.001441826],"domain_scores_gemma":[0.9972371,0.0002968836,0.0005622918,0.0008693197,0.0004634533,0.0005708823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4630091,0.02133581,0.2556337,0.0001796901,0.002755707,0.0008448081,0.007024146,0.000007627287,0.0008736935,0.02077616,0.01520823,0.2123514],"study_design_scores_gemma":[0.9349122,0.004813691,0.01480768,0.008888555,0.000008894363,0.0001347275,0.00093386,0.0001041857,0.0002498836,0.0006351304,0.03356832,0.0009428429],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9767014,0.01020271,0.0001270677,0.0005132516,0.001710873,0.005971405,0.00009545776,0.0002227382,0.004455098],"genre_scores_gemma":[0.9341037,0.06121921,0.00206098,0.0002127401,0.00005189583,0.001303545,0.0003979743,0.0001485705,0.0005013956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4719031,"threshold_uncertainty_score":0.9995694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168161533","doi":"10.1002/art.11296","title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: The Toronto Risk Factor Study","year":2003,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":392,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Risk factor; Internal medicine; Framingham Risk Score; Population; Systemic lupus erythematosus; Menopause; Diabetes mellitus; Lupus erythematosus; Disease; Immunology; Endocrinology; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.01427974783204318,"gpt":0.2672707125686724,"spread":0.2529909647366292,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001481652,0.000525122,0.001096484,0.0001470656,0.0004381341,0.0001076025,0.0003125145,0.0001268763,0.0004685141],"category_scores_gemma":[0.001232741,0.0003366519,0.0001500914,0.0003028594,0.0001852643,0.0003570857,0.00007637489,0.0004466487,0.00006008567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009424521,"about_ca_system_score_gemma":0.0004246866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002747202,"about_ca_topic_score_gemma":0.003180759,"domain_scores_codex":[0.9951058,0.0009779508,0.0009569644,0.0007986739,0.001054213,0.00110638],"domain_scores_gemma":[0.9961244,0.001411775,0.0003429214,0.001313742,0.0002004803,0.0006066904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000926423,0.0006138798,0.9646066,0.0003542851,0.000257794,0.00009700572,0.0293676,0.00002302461,0.0000241939,0.0001482264,0.0005654388,0.003015502],"study_design_scores_gemma":[0.02650862,0.003872449,0.8039823,0.006991967,0.0001550945,0.01130325,0.1442711,0.0002266887,0.00002959486,0.0008833513,0.0008692358,0.0009063795],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756879,0.01534633,0.0001900559,0.00008269268,0.0004275347,0.007616377,0.0003244525,0.0001527307,0.0001719171],"genre_scores_gemma":[0.9932312,0.003562028,0.0001649647,0.00005193012,0.00003929104,0.002421938,0.00001340429,0.0001378444,0.0003774364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1606244,"threshold_uncertainty_score":0.9999086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039200195","doi":"10.1002/art.34402","title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","year":2012,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health","keywords":"Medicine; Pregnancy; Antiphospholipid syndrome; Lupus anticoagulant; Adverse effect; Serology; Internal medicine; Prospective cohort study; Obstetrics; Multivariate analysis; Systemic lupus erythematosus; Immunology; Antibody; Thrombosis; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02139196335581143,"gpt":0.2732727299868767,"spread":0.2518807666310653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007044188,0.0003041664,0.001053861,0.0002353435,0.00008880846,0.000009954751,0.0002804094,0.0001499433,0.00005474586],"category_scores_gemma":[0.0004318112,0.0002087748,0.0001471724,0.000477508,0.0005730574,0.0004929838,0.0001568596,0.0003047483,0.00001979762],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005725477,"about_ca_system_score_gemma":0.00008386741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005971148,"about_ca_topic_score_gemma":0.00002004368,"domain_scores_codex":[0.9964459,0.0002303592,0.001157637,0.0003586739,0.001097292,0.0007101675],"domain_scores_gemma":[0.9979099,0.0002964676,0.0004436867,0.0008653637,0.0003167076,0.0001678944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002256284,0.0005034491,0.9877886,0.0008633576,0.0001433356,0.000006942187,0.001873571,0.000003737758,0.004614948,0.0001762959,0.0004350475,0.003365101],"study_design_scores_gemma":[0.00655863,0.0004188856,0.9713407,0.01301926,0.00005527903,0.0007254679,0.0006163724,0.0001010137,0.006906668,0.00001002286,0.00006115808,0.0001865498],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890303,0.007603283,0.000191501,0.00007512989,0.0005617604,0.001673704,0.0003245348,0.00004647093,0.0004932976],"genre_scores_gemma":[0.9944333,0.004815634,0.0003250438,0.00001674833,0.00003330114,0.00004096453,0.0000979394,0.00004994388,0.0001871056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01644789,"threshold_uncertainty_score":0.8513591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039207296","doi":"10.1002/art.22070","title":"Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease‐modifying antirheumatic drugs: A one‐year randomized, placebo‐controlled study","year":2006,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Abatacept; Medicine; Adverse effect; Rheumatoid arthritis; Placebo; Internal medicine; Randomized controlled trial; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01028064170936611,"gpt":0.2447227506413903,"spread":0.2344421089320242,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002303141,0.0005714879,0.002470139,0.0004443903,0.0005117375,0.0001423842,0.0002728013,0.0001889958,0.0001590565],"category_scores_gemma":[0.0019069,0.0004292519,0.0003909281,0.0006557982,0.0007897205,0.0005031526,0.000233749,0.0005441686,0.00002125491],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001838827,"about_ca_system_score_gemma":0.0001862359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001460646,"about_ca_topic_score_gemma":0.001147191,"domain_scores_codex":[0.9935277,0.001831279,0.002089665,0.000832258,0.0008989657,0.0008201245],"domain_scores_gemma":[0.9961215,0.001884048,0.0007511494,0.0006480907,0.0003533686,0.0002418153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09106462,0.003124371,0.8061522,0.0001967535,0.0007521639,0.00002166113,0.004210655,0.0005348715,0.0003328589,0.002588966,0.0001307433,0.09089011],"study_design_scores_gemma":[0.4020922,0.000563252,0.5814136,0.006180471,0.00002036716,0.00001797057,0.00113851,0.003848578,0.00003952596,0.004254496,0.00001282003,0.0004181497],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9654495,0.0248379,0.0001964738,0.0002172549,0.0001865892,0.008373215,0.00007668839,0.0001074396,0.0005549766],"genre_scores_gemma":[0.927398,0.07125451,0.0004801198,0.00003943221,0.00002291979,0.0006084803,0.0001044288,0.00005909276,0.00003304056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3110276,"threshold_uncertainty_score":0.9998159,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068354144","doi":"10.1002/art.24132","title":"Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation","year":2008,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":378,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Ankylosing spondylitis; Medicine; Spondylitis; Magnetic resonance imaging; Radiography; Radiology; Inflammation; Cohort; Prospective cohort study; Axial spondyloarthritis; Nuclear medicine; Surgery; Internal medicine; Sacroiliitis","retraction":null,"screen_n_in":null,"score":{"opus":0.04252718758140882,"gpt":0.2659268939384191,"spread":0.2233997063570103,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003152617,0.0001496968,0.0003645625,0.0001444549,0.0002108116,0.000006610191,0.00008227967,0.00005005482,0.00001663907],"category_scores_gemma":[0.0005875097,0.0001110601,0.00005769962,0.0003281587,0.000217635,0.0002990109,0.00007567197,0.000145341,0.000001684353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006182462,"about_ca_system_score_gemma":0.0002453248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002501048,"about_ca_topic_score_gemma":0.0004601994,"domain_scores_codex":[0.9982494,0.00008512545,0.0009297832,0.0001665042,0.0003931638,0.0001759968],"domain_scores_gemma":[0.9988788,0.0003173378,0.0003744408,0.0002870069,0.00008117052,0.0000612385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0000634087,0.00002577782,0.6697428,0.0001396401,0.00001181228,0.0000101199,0.008259238,0.00000763433,0.0005773981,0.0005819864,0.00006978372,0.3205104],"study_design_scores_gemma":[0.002342281,0.0001879514,0.9772329,0.01610489,0.00002516706,0.0001122604,0.0002680916,0.00004561426,0.002768924,0.000698371,0.0001342164,0.00007935011],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9457803,0.05255462,0.0001166223,0.0007465999,0.00004738557,0.0006441661,0.00001231002,0.00001367368,0.00008430849],"genre_scores_gemma":[0.9934959,0.003780404,0.002575757,0.00001203681,0.00002809459,0.00002498954,0.00001293386,0.0000125939,0.00005724333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3204311,"threshold_uncertainty_score":0.4528899,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}